Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,010
Ph III recruiting: 99
Growth YoY: −1.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,348)

clinicaltrialsPublishedShowing 3,501–3,502 of 3,502 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00209833	Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T	unknown	Phase 2 / Phase 3	200	Hannover Medical SchoolOTHER	1	Nov 18, 2005	clinicaltrials
NCT00083473	A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia	terminated	Phase 2	28	Titan PharmaceuticalsINDUSTRY	1	Aug 30, 2005	clinicaltrials